Kidneys Archives - Harry Perkins Institute of Medical Research

About Us
About Perkins

Since 1998, the Perkins has grown to become one of the nation's leading adult medical research centres, where a close-knit team of more than 450 research and clinical staff work together to defeat the major diseases that impact our community.
Research
Research

Perkins researchers focus on some of the major diseases that affect our community. In particular we focus on cancer, diabetes, heart disease and neuromuscular diseases.
Support the Perkins
Support the Perkins

Your support will help us to deliver a healthier future through medical breakthroughs, new treatments and fostering the next generation of scientific talent.
Get Involved
Get Involved

You can support Perkins work in many different ways. From participating in an event, to attending a workshop in the BioDiscovery Centre, to volunteering your time, or supporting our research, we welcome your involvement.
Donate

Antibiotic diagnostics Bacteria Kidneys News & Events Targeted Drug Delivery

Federally funded WA biomedical start-ups

By Richard Schoonraad | Antibiotic diagnostics, Bacteria, Kidneys, News & Events, Targeted Drug Delivery

Cutting-edge biopolymer 3D printed heart valve technology and a rapid and accurate test to identify the most effective antibiotic treatment have commenced commercialisation in Western Australia to help millions globally.…

Biomedical engineering Blood Vessels Cardiovascular Disease Cardiovascular Disease Cardiovascular Science and Diabetes Program Chronic Kidney Disease Disease Area Kidney Disease Kidneys Media Releases News & Events Vascular Engineering

Tiny filters with big roles for patients with chronic kidney disease

By Alicia Bienkowski | Biomedical engineering, Blood Vessels, Cardiovascular Disease, Cardiovascular Disease, Cardiovascular Science and Diabetes Program, Chronic Kidney Disease, Disease Area, Kidney Disease, Kidneys, Media Releases, News & Events, Vascular Engineering

Perth bioengineers investigate critical device for dialysis machines Fast facts An estimated 1.7 million or 10% of Australian adults have Chronic Kidney Disease (CKD) An estimated 1 in 5 or…

Chronic Kidney Disease Funding Kidney Disease Kidneys Media Releases Molecular Endocrinology and Pharmacology Molecular Medicine News & Events Research Area

$20M for biopharm DIMERIX to fund phase 3 trials for rare kidney disease

By Alicia Bienkowski | Chronic Kidney Disease, Funding, Kidney Disease, Kidneys, Media Releases, Molecular Endocrinology and Pharmacology, Molecular Medicine, News & Events, Research Area

Biopharmaceutical company, Dimerix (ASX: DXB), which is developing new treatments for types of inflammatory kidney and respiratory diseases, announced it has successfully raised $20 million to fund Phase 3 trials…

Important information

All donations of $2 and over are tax deductible in Australia.

Perkins is registered with the Australian Taxation Office as a Deductible Gift Recipient (DGR): Charitable Fundraising Authority No DGR CC20761

The Harry Perkins Institute of Medical Research recognises Australia’s first healers and scientists, the Aboriginal and Torres Strait Islander peoples. We acknowledge the Whadjuk people of the Noongar nation, the Traditional Custodians of the lands where we live and work, and pay respects to their elders past and present.

Site by Marlin - A Strategy. Creative. Digital. Agency Dedicated to Non Profit Organisations

Kidneys

Federally funded WA biomedical start-ups

Tiny filters with big roles for patients with chronic kidney disease

$20M for biopharm DIMERIX to fund phase 3 trials for rare kidney disease

Get in touch

I’m looking for

Connect with us

Important information